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From January 1982 to December 1988, 203 consecutive patients
were selected for early valve replacement (mean 10 days from time
or admission) if they had clinical evidence of native valve en-
docarditis with 1) vegetations on echocardiography, 2) severe
valvular lesions, and 3) heart failure . Surgery was performed
within 7 days of admission in 56% of patients and was done
urgently because of hemedynamic deterioration in 108 (53%) . All
vegetations were identified by echocardiography and confirmed
macroscopically at surgery .
One hundred ten patients had isolated aortic valve infection, 50
had isolated mitral valve infection (p < 0 .05 for aortic vs. mitral)
and 43 had double-valve infection. Mean aortic cross-clamp lime
was 57, 38 and 67 min, respectively . Sixty-four patients (32%) had
extensive infection involving the anulus or adjacent tissues, or
both ; such infection more frequently involved the aortic than the
mitral valve (p < 0.05)
. Thirty-eight patients (35%) with aortic
Medical therapy for endocarditis complicated by heart fail-
ure is associated with an unacceptably high in-hospital
mortality rate compared with surgical treatment, the differ-
ence being as much as 56% versus 11% (H. Most deaths in
medically treated patients result from heart failure and
recurrent systemic et. bolism (2-8)-
For these reasons, it is
generally accepted that surgical intervention is the preferred
form of treatment for endocarditis complicated by heart
failure (9-12).
Although surgery has improved survival in
this group of patients, the operative mortality rate is still in
the range of 10% to 35% (2,9-24), However, there is still a
tendency to postpone surgery in this critically ill group of
patients in the hope of controlling infection because of the
risk of prosthetic valve infection and technical difficulties of
operating on friable annular tissues (10,18) .
In view of uncertainty regarding the optimal timing of
surgical intervention, in 1982 we adopted an approach of
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valve infection had abscess formation compared with I patient
(2%) with mitral valve infection (p < 0 .05) . Only eight patients
(4%) died in the hospital . There were seven patients (3%) with a
periprosthetic leak and five patients (3%) with early prosthetic
valve endocarditis. Long-term follow-up, available in 174 hospital
survivors (89%), revealed 10 deaths and two now ring leaks at 38
22 months .
In conclusion, among patients with endocarditis who need
surgery for heart failure, aortic valve infection is more prevalent
than mitral valve infection and is more often associated with
extensive infection, including abscess formation. However, even
the presence of heart failure and extensive infection is not neces-
sarily associated with high surgical risk when surgery is per-
formed early .
(J Am Coll Cordial 1991 ;18:663-7)
referring for early surgery all patients who had congestive
cardiac failure due to valvular dysfunction and vegetations
on echocardiographic evaluation (25-28) . The purpose of
this study was to examine the results of this management
policy in a large group of patients with active vegetative
endocarditis. We also addressed the question of whether
extensive infection (for example, abscesses or fistulas) ad-
versely affects surgical outcome and whether outcome and
macroscopic findings at surgery differ for aortic . mitral or
double valve infection.
Methods
Study patients. We retrospectively analyzed records for
203 consecutive hemodynamically compromised patients
with vegetative native valve bacterial endocarr2!is who
underwent valve surgery between January I, 1982 and
December 31, 1988 . In all these patients. there was macro-
scopic evidence of endocarditis at surgery (vegetations and
signs of active inflammation with or without abscess forma-
tion)
. There were 119 men and 84 women, aged 6 to 72 years
(mean 33 ± 13) . On admission, 91 (45%) were in New York
Heart Association functional class Ill and 112 (55%) were in
class IV . Just before operation, 2 patients had a cardiac
arrest and 19 were in a low output state (systolic blood
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Before surgery. 23 patients sustained major systemic embo-
lism (16 cerebral . I coronary and 8 peripheral)
. No patient
had complete heart block or myocardial infarction ; 17 pa-
tients had first degree block, I had right and I had left bundle
branch block . Blood cultures, valve histologic data and
culture results were sought in all cases . Comprehensive
surgical reports were available for all patients . These in-
cluded detailed macroscopic findings of abnormalities on the
left side of the heart and aortic cross-clamp times .
Echocardiography. All 203 patients were evaluated by
echocardiography with the use of the MK5 or UM8 ATL
echocardiography system as soon as the clinical diagnosis of
congestive cardiac failure was made on the basis of a
valvular lesion . Vegetations were diagnosed by echocardiog-
raphy according to the criteria of Gilbert et al . (29). There
were 50 patients (259e) with vegetations on the mitral valve
alone . 110(54%) with vegetations on the aortic valve alone
and 43 (219) with vegetations on both valves (Table 1)
.
Bacteriologic data . Blood culture results were available
in 83 of the 203 patients . Of these, 42 (50%) were positive
(Snrptororcus Iiridars 20. Stuplrvlarareas epiderret(dis 8,
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Valve histologic results were available in 67 of the 203
patients
. In all 67 patients . the histologic findings were
compatible with infective endocarditis
. Valve culture
yielded gram-positive cocci in 8 patients and a gram-negative
bacillus in I patient
. Overall . blood culture results or his-
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tologic data, or both . were available in 109 patients and
bacteria were present in 91% of these patients .
Preoperative management . Patients were given oral or
intravenous diuretic therapy . or both, with afterload-
reducing agents. Antibiotic therapy was initiated with intra-
venous crystalline penicillin G (2 million U every 4 h),
cloxacillin (4 to 6
g
every 24 h) and an aminoglycoside and
was subsequently altered according to bacteriologic data .
Those patients whose condition could be stabilized on
medical treatment but who still had evidence of heart failure
were referred for surgery within a few days . Those who did
not respond satisfactorily underwent urgent operation within
24 to 48 h . Cardiac catheterization was not performed in the
majority of cases . The time interval from admission to
surgery was <7 days in 56% of patients (<24 h in 50, 24 to
48 h in 18.48 to 96 h in 20
.5 to 7 days in 25, 8 to 14 days in
47 and >2 weeks in 43) .
Postoperative management . All patients continued with
appropriate intravenous broad spectrum antibiotic treatment
for 4 weeks in those without and 6 weeks in those with
extensive infection . Therapy for heart failure was continued
when necessary .
Surgical technique. The cardiopulmonary bypass proce-
dure was standard with moderate hypothermia (25 ° to 28°C)
and intermittent irrigation of the pericardial cavity with iced
saline solution . Cardioplegic solution (24 mEq/liter of potas-
sium) for myocardial protection was given directly into both
coronary orifices or the aorta and replaced as necessary
every 20 to 25 min . Infected tissue was removed as com-
pletely as possible . Removal was achieved readily in the
regions of infected mitral valve but proved more difficult in
the aortic valve area if infection had spread to the aortic wall
or subjacent tissues, or both . A mitral valve prosthesis was
implanted with continuous sutures in all but 19 of 58 pa-
tients ; interrupted sutures were used for all aortic prosthe-
ses . Aortic cross-clamp time was 38 min for patients with
mural valve infection. 57 min for aortic valve infection and
67 min for double valve infection .
Definitions . Extensive infection was defined as present
when infection extended beyond the anatomic confines of
the valve leaflets and involved the anulus or adjacent tissues,
or both . Surgery was defined as urgent when medical ther-
apy failed to achieve a satisfactory improvement in hemo-
dynamics during the hospital stay, necessitating surgery
within 24 to 48 h
.
Statistical methods. The results were analyzed for statis-
tical significance with use of the Mann-Whitney U test and
chi-square analysis .
Results
Surgical findings and procedures . Fifty patients (25%)
had vegetations on the mitral valve ; 43 of the 50 had mitral
valve replacement . 2 had mitral valve repair and 5 had
double-valve replacement for associated aortic valve dis-
ease . Vegetations were confined to the aortic valve in 110
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patients (54 0fl ; 95 of the 110 had aortic valve replacement
and 15 had a double-valve replacement for associated mitral
valve disease
. Vegetations were found on both valves in 43
patients (21%) ; 30 of the 43 patients had double-valve
replacement and 13 had aortic valve replacement with de
-
bridement of the mitral valve apparatus .
Surgery was performed urgently in 108 patients (53%) : on
the day of admission in 50 patients, on day 2 in 15 . between
3 and 7 days after admission in 29 and after I week in 14.
Sixty-two (56%) of the 108 patients had aortic valve infec-
tion, 18 (36%) had mitral valve infection and 28 (65%) had
double-valve infection (Table 1) . A mechanical prosthesis
was implanted in 247 valves (41% St Jude's, 57% Medtronic
Hall, 2% other) and a tissue valve in 4 . Aortic root recon-
struction using an autologous or bovine pericardial patch or
woven Dacron graft was required in 13 patients (6%). Four
patients had a mycotic aneurysm of the aortic root, one of
which had dissected preoperatively . Additional procedures
performed for abnormalities unrelated to endocarditis in-
cluded closure of a perimembranous ventriculoseptal defect
in two cases, ligation of a patent ductus arteriosus and
closure of a pasttraumatic aortopulmonary fistula .
Infection of the aortic valve was more pres-anent that
mitral infection (54% vs
. 25%, p < 0.05, Table 1)
. One
hundred thirty-nine patients (68%) had limited infection (43
mitral, 65 aortic and 31 double-valve infective endocarditis)
and 64 patients (32%) had extensive infection (7 mitrai, 45
aortic and 12 double-valve infective endocarditis) . Thirty-
one patients (15%) had a pericardial effusion ; in 13 of the 31
there was associated abscess formation . There were five
fistulas (one aorta to right ventricle, one aorta to pulmonary
artery, one aorta to pericardium, one ventriculoseptal defect
and one aorta to right atrium). All fistulas occurred in
association with infection of the aortic valve (Table 1).
There were 153 infected aortic valves (46 were totally
destroyed, 26 had perforated cusps and 18 had fibrosis or
calcification) . Of the 93 infected mitral valves, 6 had a
perforated cusp and 46 had a flail leaflet due to ruptured
chordae tendineae. Infection resulted in abscess formation in
46 patients (23%) . In the group as a whole, there were 19
annular, 9 supraannular, 13 subannular and 5 multiple ab-
scesses. These were found in 38 (35%) of 110 patients with
aortic valve infection compared with 1 (2%) of 30 patients
with mitral valve infectior (p < 0 .001)
. Double-valve infec-
tion was complicated by abscess formation in 7 (16%) of 43
patients (Table p .
Early postoperative mortality . There were eight deaths
postoperatively . resulting in an in-hospital mortality rate of
4% (Table I) . Death was attributed to cerebral or coronary
embolism in two patients, pump failure in two, sepsis in two
and multiple organ failure in two . Seven of these had
infection of the am iic valve, which was extensive in five and
limited in two . Urgent surgery had been required in all
patients who died . Among these patients, surgery was per-
formed within 48 h of admission in six, at 8 days in one and
at 62 days in one . The aortic cross-clamp time was 68 min in
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patients who died and 54 min in those who survived (p <
0 .02) . Six of the eight patients who died had major systemic
embolism before operation (cerebral in four, coronary in one
and peripheral in one) .
Early postoperative morbidity . Of the 203 patients. 7 (3%)
had a periprosthetic leak that did not require reoperation
during the hospital stay; 5 had associated prosthetic valve
endocarditis. I of whom had a fistula extending from the
aortic anulus to the right ventricle (Table I) . Two of these
patients required repeat operation 4 months after the initial
operation . Two additional patients had complete heart block
postoperatively, requiring permanent pacemaker implanta-
tion.
Late postoperative morbidity and mortality
. Of the 195
hospital survivors, long-term follow-up was available in 174
(89%) . The others were lost to follow-up because they were
from other countries (n = 15) or rural areas of South Africa
(n = 14) . The mean follow-up interval was 38 ± 22 months
(range 4 to 99). There were 10 late deaths (6%)- 2 of which
were definitely valve-related ; one patient died of heart
failure due to cardiomyopathy, one from inplnes after an
assault and six from undetermined causes- Death in 3 of the
l0 patients occurred within the I st year, and these were the
only patients followed up for < I year . A hemodynamically
significant ring leak was diagnosed late in two patients ; one
was reoperated on successfully and the other was managed
medically . One patient was reoperated on late for a throm-
hosed valve .
Discussion
This study of surgery for active endocarditis is unique in
terms of 1) the total number of patients, 2) the number of
patients with heart failure, 3) the number of patients with
double valve infection, 4) the short period of time from
di,gnosis to surgery, and 5) the surgical outcome . Despite
the severe degree of hemodynamic compromise, extensive
infection and the large number of patients with double valve
involvement, the surgical results were excellent . We at-
tribute this outcome to the early timing of surgery, with the
correction of hemodynamic compromise and prevention of
preoperative sequelae such as multiple organ failure, embo-
lization and progressive sepsis, all of which we believe
increase the risk of deferring surgery.
Tuning of surgical intervention
. The proper timing of
surgery is critical in the management of these patients.
Procrastination to achieve a sterile surgical field results in
irreversible myocardial damage in patients with hemody-
namic dysfunction (l2) and in the continued deterioration of
renal or neurologic function, which precludes a successful
surgical outcome or leaves a major residual defect (14,23),
Once heart failure develops in the course of the illness, it
tends to be progressive even though it may respond tempo-
rarily to medical measures
. Surgery should be performed
within days of the development of heart failure (28) because
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the infected valve can be safely replaced, regardless of the
infective state of the patient (2,13,16,30) .
Despite these results and the recommendation that sur-
gery he performed early, the intervo! r:om diagnosis to
surgical intervention in previous studies has not been as
short as in our study or has not been specified, with several
exceptions. Richardson et al . (2) reported a 14% mortality
rate in 81 patients referred for surgery at an average of 21
days after admission and Young et al . (16) reported a 37%
operative mortality rate in 30 patients operated on 10 to 27
days after admission
. In studies (25-28) from our institution
.
the time interval ranged from I to 12 days after admission
and the mortality rate ranged from 7% to 10%. In the present
study
. the mean interval from admission to surgery was 10
days and there was no significant difference in time intervals
among mitral, aortic or double valve involvement
. More-
over, 56% of these patients underwent surgery within 7 days .
Congestive heart failure in mitral versus aortic valve en-
docarditis . Congestive heart failure has been shown to be
the most important prognostic indicator of death in patients
treated medically (16 .31,32) . Although medical cure rates of
50% to 90% can be achieved in uncomplicated active en-
docarditis (29,33), the mortality rate is high (25% to 89%)
when infection is complicated by heart failure (1,31,34,35) .
Richardson et al . (2) reported the mortality rate associated
with valve replacement to be 6% with mild failure, 20% with
moderate failure and 33% with severe failure . Because of the
high mortality r ate at operation in patients with uncontrolled
severe heart failure, operation is recommended at the first
signs that mild heart failure is worsening, regardless of the
length of prior antibiotic therapy
(31).
In view of these
findings, our excellent results in patients with heart failure
require explanation. One factor may be !hat more recent
myocardial preservation techniques result in a lower mortal-
ity rate than that achieved with techniques used in previous
decades. Another factor may have been a relatively lower
incidence of preoperative embolization and multiorgan fail-
ure than in some other studies (14,36) . A third factor may be
the young age of our patients . Also contributory is the
experience of our surgeons, as indicated by the large number
of patients in our series with extensive infection .
Although endocarditis occurs most frequently on the
mitral valve, surgery is more often performed for aortic
valve infection because of heart failure
(9,12)
.
Once infection
occurs on the aortic valve, the degree of destruction is much
more extensive and results more frequently in heart failure .
Acute severe aortic regurgitation is notoriously deadly, more
so than acute severe mitral regurgitation, probably as a
result of the left ventricle being less compliant than the left
atrium, with tesultant left ventricular end-diastolic pressure
that is higher in aortic regurgitation . In our series, isolated
aortic valve infection complicated by heart failure was also
more prevalent than mitral valve infection (54% vs . 25%, p <
0.A5) . Ako of note is the high prevalence (21%) of double-
valve infection in our consecutive group of patients (Table
1)
. Rheumatic fever with its propensity to affect multiple
JACC Vol. IS . No . 3
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valves is the most common cause for valvular dysfunction in
these patients . This, together with possible diminished host
resistance or more virulent organisms, or both, might ac-
°t for she higher ide of double valve infection (2 5)
Extensive Infection In mitral versus aortic valve endocardi .
tis. Our study is remarkable for the following findings .
There was a high incidence (32%) of extensive infection in
the study group. Abscess formation was found in 46 (23%) of
the 203 patients . In the 64 patients with extensive infection,
46 (72%) had associated abscess formation
. The latter,
usually related to the infected valve anulus, is the typical
manifestation of extensive infection in isolated aortic valve
endocarditis (80%) . In contrast, extensive infection in iso-
lated mitral valve endocarditis is rarely associated with
abscess formation (38 of 45 vs . I of 7, p < 0
.05)
. Also,
infection was more often extensive on the aortic than on the
mitral valve (41% vs, 14%, p < 0.05) . Similarly, Becker et al .
(36) reported no case with mitral valve infection associated
with an abscess containing actively infected material . This
finding should justify an aggressive management strategy in
aortic endocarditis, with early surgical intervention to pre-
vent myocardial rupture. It has been suggested (37) that a
pericardial effusion is highly suggestive of an annular ab-
scess associated with aortic valve infection . There were 31
pericardial effusions, of which 13 (42%) had abscess forma-
tion . In the majority of patients, the presence of an effusion
is probably reactive to infections in cases where there is no
obvious extension of infection to the pericardium or possibly
to heart failure. It is noteworthy that, despite evidence of
vegetations and abscess formation at surgery, many of our
patients had negative blood and valve cultures, probably as
a result of the administration of antibiotics before referral .
A mechanical prosthesis was implanted in the majority of
patients . In a similar group of patients, other investigators
(38) have reported an overall 6% incidence of reoperation for
endocarditis in patients with a mechanical prosthesis versus
20% for those with a bioprosthetic valve . Despite the pres-
ence of extensive infection in 41% of patients with aortic
valve involvement, mechanical valve implantation as op-
posed to homograft utilization did not preclude a good
short-term (39) and long-term result.
Conclusion. The presence of heart failure and extensive
infection in left-sided valve endocarditis is not necessarily
associated with high surgical risk when surgery is performed
early . Early surgical intervention in these critically ill pa-
tients has acceptably low mortality and morbidity and is the
optimal form of treatment .
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